<DOC>
	<DOCNO>NCT01596023</DOCNO>
	<brief_summary>The Breathe Ventilator lightweight , wearable ventilator receive U.S. FDA clearance use patient respiratory difficulty . The investigator believe Breathe NIOV system reduce work diaphragm breathe provide added tidal volume oxygen . This study 14 patient severe-to-very severe chronic obstructive lung disease ( COPD ) ass work breathe use NIOV system measure esophageal stomach pressure .</brief_summary>
	<brief_title>Evaluation Breathe NIOV System Work Breathing Chronic Obstructive Lung Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>1 . Subject &gt; 18 year age time consent . 2 . Subject diagnosis severe COPD ( GOLD stage III IV ) demonstrate FEV1 &lt; 50 % predict FEV1/FVC ratio &lt; 70 % predict . 3 . Subject increase inspiratory muscle work breathing evidence palpable sternocleidomastoid muscle contraction inspiration 1 . Subject acute exacerbation COPD within 1 week acute hospitalization 2 . Subject respiratory rate rest &gt; 28/min 3 . Subject require &gt; 5 L/min nasal O2/min maintain O2sat &gt; 90 % 4 . Subject severe dyspnea rest 5 . Subject swallow disorder chronic aspiration , prior esophageal surgery , condition would place subject risk balloon placement . 6 . Subject history pneumothorax secondary lung bulla . 7 . Subject cognitively impaired give subjective rating visual analog scale 8 . Subject sensitivity allergy lidocaine 9 . Subject known history oxygen intolerance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>COPD</keyword>
</DOC>